SEC
ABMD

Seven Eight Capital’s Abiomed Inc ABMD Stock Holding History

Seven Eight Capital’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-11,600
Closed -$3.02M – 767
2019
Q2 		$3.02M Buy
+11,600
New +$3.08M 0.16% 191
2018
Q4 		– Sell
-1,200
Closed -$540K – 754
2018
Q3 		$540K Hold
1,200
– – 0.03% 446
2018
Q2 		$491K Buy
+1,200
New +$435K 0.03% 361
2017
Q3 		– Sell
-700
Closed -$100K – 660
2017
Q2 		$100K Buy
+700
New +$94.1K 0.01% 441
2017
Q1 		– Sell
-5,800
Closed -$654K – 718
2016
Q4 		$654K Buy
+5,800
New +$672K 0.13% 249

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Seven Eight Capital's ABMD Position: Q3 2019 in Review

Seven Eight Capital sold out of Abiomed Inc (ABMD) in Q3 2019, closing a stake of 11,600 shares — an estimated $3.02M sold.

Seven Eight Capital first reported a position in ABMD in Q4 2016 and held it in 5 quarters. The position peaked at $3.02M in Q2 2019. 443 funds tracked by Wall St. Rank hold ABMD as of Q3 2019.

  • Seven Eight Capital reported no remaining Abiomed Inc position as of Q3 2019 after selling out during the quarter.
  • Seven Eight Capital sold 11,600 Abiomed Inc shares in Q3 2019, an estimated $3.02M.
  • Seven Eight Capital first reported a position in Abiomed Inc in Q4 2016 and held it in 5 quarters.
  • Seven Eight Capital's Abiomed Inc position peaked at $3.02M in Q2 2019.
  • 443 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2019.

Based on Seven Eight Capital's 13F filing for Q3 2019, filed 14 Nov 2019.